| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |